Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Falling

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Dec 21, 2021 2:43pm

129 Views

Post# 34251616

RE:Falling

As I have said before, there are two explanations for thier seemingly incompetence of bolstering the share price:

They are woefully incompetent at this side of the business
They don't give a hoot of what the share price is this week or next, because they know it will ultimately correct itself when they publicize the Phase 1/1a results

-LT

Bucknelly21 wrote: Doesn't appear the selling is done, and in the mean time Thtx is sitting on its hands not even trying to support it. They just don't seem to understand the game

<< Previous

Bullboard Posts

Next >>

UniDoc brings AI-powered H3 Health Cube to Italy